Development of an HPLC-MS procedure for the quantification of N-acetyl-S-(n-propyl)-l-cysteine, the major urinary metabolite of 1-bromopropane in human urine

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 877, Issue 8-9, 2009, Pages 827-832

  Cheever, K L ^a   Marlow, K L ^a   B'Hymer, C ^a   Hanley, K W ^a   Lynch, D W ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

1 Bromopropane; HPLC MS

Indexed keywords

ACETONE; ANIMALS; BODY FLUIDS; ELECTROSPRAY IONIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METABOLITES; SOLAR RADIATION;

1-BROMOPROPANE; ANALYTICAL PROCEDURES; HEALTH CONCERNS; HPLC-MS; HUMAN URINES; INDUSTRIAL SOLVENTS; INDUSTRIAL WORKERS; INTERNAL STANDARDS; L CYSTEINES; LIMIT OF DETECTIONS; MULTIPLE LEVELS; N PROPYLS; NEGATIVE ION; NEUROLOGICAL DISORDERS; RELATIVE STANDARD DEVIATIONS; SELECTED-ION-MONITORING; SOLID-PHASE EXTRACTIONS; TEST PROCEDURES; URINARY METABOLITES; URINE SAMPLES; WATER SOLUTIONS;

EXTRACTION;

1 BROMOPROPANE; BIOLOGICAL MARKER; BROMINE DERIVATIVE; METHANOL; N ACETYL S (N PROPYL)CYSTEINE; PROPANE; UNCLASSIFIED DRUG;

ARTICLE; ELECTROSPRAY; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INDUSTRIAL WORKER; ION MONITORING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SOLID PHASE EXTRACTION; STANDARD; URINALYSIS;

ACETYLCYSTEINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; HYDROCARBONS, BROMINATED; MASS SPECTROMETRY;

ANIMALIA;

EID: 61349130780     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2009.02.010     Document Type: Article

References (39)

1. Yu X., Ichihara G., Kitoh J., Xie Z., Shibata E., Kamijima M., Asaeda N., and Takeuchi Y. J. Occup. Health 40 (1998) 234
2. Hoet P., and Haufroid V. Occup. Environ. Med. 54 (1997) 361
3. Ichihara G., Yu X., Kitoh J., Asaeda N., Kumazawa T., Iwai H., Shibata E., Yamada T., Wang H., Xie Z., Maeda K., Tsukamura H., and Takeuchi Y. Toxicol. Sci. 54 (2000) 416
4. Fueta Y., Ishidao T., Kasai T., Hori H., and Arashidani K. J. Occup. Health 42 (2000) 149
5. Ichihara G., Miller K., Ziolkowska A., Itohara S., and Takeuch Y. J. Occup. Health 44 (2002) 1
6. Majersik J.J., Caravati E.M., and Steffens J.D. Clin. Toxicol. 45 (2007) 270
7. Ohnishi A., Ishidao T., Kasai T., Arashidani K., and Hori H. J. UOEH 21 (1999) 23
8. Fueta Y., Fukunaga K., Ishidao T., and Hori H. Life Sci. 72 (2002) 521
9. Sclar G. Clin. Neurol. Neurosurg. 101 (1999) 199
10. Yamada T., Ichihara G., Wang H., Yu X., Maeda K.-i., Tsukamura H., Kamijima M., Nakajima T., and Takeuchi Y. Toxicol. Sci. 71 (2003) 96
11. Lee E., Moon Y., Zhao L., Kim E., Lim H., Basnet A., Jeong T., and Chae W. Toxicologist 72 (2003) 206
12. Toraason M., Lynch D.W., DeBord D.G., Singh N., Krieg E., Butler M.A., Toennis C.A., and Nemhauser J.B. Mutat. Res. 603 (2006) 1
13. Ichihara G., Amarunasu K., Amarunasu B., Barentain H., Li W., Wang H., and Barentain W. Sangyo Eiseigaku Zasshi 46 (2004) 298
14. Valentine H., Amarnath K., Amarnath V., Li W., Ding X., Valentine W.M., and Ichihara G. Toxicol. Sci. 98 (2007) 427
15. Barnsley E.A., Grenby T.H., and Young L. Biochem. J. 100 (1966) 282
16. Ichihara G., Ding X., Yu X., Wu X., Kamijima M., Peng S., Jiang X., and Takeuchi Y. Am. J. Ind. Med. 35 (1999) 523
17. Takeuchi T., Okuda H., Arito H., Nagano K., Yamamoto S., and Matsushima T. Reprod. Toxicol. 18 (2004) 431
18. Kim Y., Jung K., Hwang T., Jung G., Kim H., Park J., Kim J., Park J., Park D., Park S., Choi K., and Moon Y. Scand. J. Work Environ. Health 22 (1996) 387
19. Park J., Kim Y., Park D., Choi K., Park S., and Moon Y. J. Occup. Health 39 (1997) 138
20. Baines P.J., Bray H.G., and James S.P. Xenobiotica 7 (1977) 653
21. Barnsley E.A. Biochem. J. 100 (1966) 362
22. Grenby T.H., and Young L. Biochem. J. 75 (1960) 28
23. Jones A.R., and Walsh D.A. Xenobiotica 9 (1979) 763
24. Tachizawa H., MacDonald T.L., and Neal R.A. Mol. Pharmacol. 22 (1982) 745
25. Garner C.E., Sumner S.C.J., Davis J.G., Burgess J.P., Yueh Y., Demeter J., Zhan Q., Valentine J., Jeffcoat A.R., Burka L.T., and Mathews J.M. Toxicol. Appl. Pharmacol. 215 (2006) 23
26. Lee D.-S., Wu C., and Hill H.H. J. Chromatogr. A 822 (1998) 1
27. Kawai T., Takeuchi A., Miyama Y., Sakamot K., Zhang Z., Higashikawa K., and Ikeda M. Biomarkers 6 (2001) 303
28. Hanley K.W., Petersen M., Curwin B.D., and Sanderson W.T. Ann. Occup. Hyg. 50 (2006) 599
29. B'Hymer C., and Cheever K.L. J. Chromatogr. B 802 (2004) 361
30. B'Hymer C., and Cheever K.L. J. Chromatogr. B 814 (2005) 185
31. Pombrio J.M., Giangreco A., Li L., Wempe M.F., Anders M.W., Sweet D.H., Pritchard J.B., and Ballatori N. Mol. Pharmacol. 60 (2001 1091)
32. Cheever K.L., Marlow K.L., Stinson D., Teass A.W., and DeBord D.G. Toxicol. Sci. 66 (2002) 28
33. K.W. Hanley, M. Petersen, K.L. Cheever, L. Luo, Ann. Occup. Hyg., in press.
34. B'Hymer C., and Cheever K.L. Determination of biomarkers and metabolites by HPLC. In: Cazes J. (Ed). Encyclopedia of Chromatography. third ed. (2007), Taylor and Francis, London
35. Ichihara G., Amarnath K., Amarnath V., Valentine H., Li W., Wang H., and Valentine W. Toxicol. Sci. 78 (2004) 106
36. NIOSH, Workers' exposurers to n-propyl bromide at an adhesives and coatings manufacturer. U. S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Cincinnati, OH, IWSB 232.16, 2007.
37. The Federal Register 60 40 (1995) 11259
38. Green J.M. Anal. Chem. 68 (1996) 305A
39. Van Bladeren P., Buys W., Breimer D.D., and Vandergena A. Eur. J. Med. Chem. 15 (1980) 495